Retracted Alzheimer’s Paper Reshapes Research Landscape, but Progress Continues

In June 2024, a groundbreaking Alzheimer's research paper was retracted over fraud allegations. Did this mean billions of dollars and countless hours of research were wasted? Maybe not. Today, two promising drugs targeting amyloid beta, the focus of the paper, are available. This video explains the amyloid-beta hypothesis, the fraud, and what’s next.
Read Entire Article

© 2024 Thiratti. All rights reserved.